Provided by Tiger Fintech (Singapore) Pte. Ltd.

Terns Pharmaceuticals, Inc.

3.90
-0.1000-2.50%
Post-market: 3.900.00000.00%16:11 EDT
Volume:1.06M
Turnover:4.20M
Market Cap:340.62M
PE:-3.61
High:4.09
Open:4.03
Low:3.87
Close:4.00
Loading ...

U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp

Reuters
·
28 Feb

Terns Pharmaceuticals initiated with a Market Perform at William Blair

TIPRANKS
·
28 Feb

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
27 Feb

JMP Securities Sticks to Its Buy Rating for Terns Pharmaceuticals (TERN)

TIPRANKS
·
26 Feb

BRIEF-Terns Pharmaceuticals Cash & Cash Equivalents Expected To Provide Runway Into 2028

Reuters
·
25 Feb

Terns Pharmaceuticals: Cash & Cash Equivalents Expected to Provide Runway Into 2028

THOMSON REUTERS
·
25 Feb

Terns Pharmaceuticals: on Track to Initiate Tern-601 Phase 2 Falcon Study in Early 2Q25 With 12-Week Data Expected 2H25

THOMSON REUTERS
·
25 Feb

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

GlobeNewswire
·
25 Feb

Terns Pharmaceuticals Appoints Andrew Gengos as CFO

TIPRANKS
·
25 Feb

Terns Pharmaceuticals appoints Andrew Gengos as CFO

TIPRANKS
·
25 Feb

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

THOMSON REUTERS
·
25 Feb

Press Release: Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

Dow Jones
·
25 Feb

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Feb

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
04 Feb

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Jan

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
03 Jan

Terns Pharmaceuticals Positioned for Success with Promising Oral Therapy TERN-601 Amid Novo Nordisk’s Setback

TIPRANKS
·
21 Dec 2024